(Q44560495)

English

Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection

scientific article published on 28 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection (English)

1 reference

Europe PubMed Central

4 December 2017

Paolo de Fabritiis

1

1 reference

Europe PubMed Central

4 December 2017

author name string

A Spagnoli

2

1 reference

Europe PubMed Central

4 December 2017

P Di Bartolomeo

3

1 reference

Europe PubMed Central

4 December 2017

A Locasciulli

4

1 reference

Europe PubMed Central

4 December 2017

L Cudillo

5

1 reference

Europe PubMed Central

4 December 2017

G Milone

6

1 reference

Europe PubMed Central

4 December 2017

A Busca

7

1 reference

Europe PubMed Central

4 December 2017

A Picardi

8

1 reference

Europe PubMed Central

4 December 2017

R Scimè

9

1 reference

Europe PubMed Central

4 December 2017

A Bonini

10

1 reference

Europe PubMed Central

4 December 2017

L Cupelli

11

1 reference

Europe PubMed Central

4 December 2017

P Chiusolo

12

1 reference

Europe PubMed Central

4 December 2017

A Olivieri

13

1 reference

Europe PubMed Central

4 December 2017

S Santarone

14

1 reference

Europe PubMed Central

4 December 2017

M Poidomani

15

1 reference

Europe PubMed Central

4 December 2017

S Fallani

16

1 reference

Europe PubMed Central

4 December 2017

A Novelli

17

1 reference

Europe PubMed Central

4 December 2017

I Majolino

18

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

28 May 2007

1 reference

Europe PubMed Central

4 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

4 December 2017

40

1 reference

Europe PubMed Central

4 December 2017

3

1 reference

Europe PubMed Central

4 December 2017

245-249

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705720

0 references

Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

21 January 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

[Role of surgery in the treatment of pulmonary aspergillosis]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705720

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705720

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44560495&oldid=2155729808"